Seth M. Pollack, MD, Fred Hutchinson Cancer Research Center, explains Undifferentiated Pleomorphic Sarcoma Can respond to checkpoint blockade like pembrolizumab at Annual Meeting 2018
Undifferentiated Pleomorphic Sarcoma Can respond to checkpoint blockade like pembrolizumab
